Companies: 10,795·Total market cap: $144.5T
Kronos Bio, Inc.

Kronos Bio, Inc.

KRONNASDAQHealthcare
$0.88
+$0.01(+1.49%)
Market Cap$53652896
P/E Ratio
52W High$1.46
52W Low$0.65

Kronos Bio, Inc. (KRON) Revenue

Annual & quarterly revenue history · segment & region breakdown

KRON · revenue · updated Jun 9, 2026

Core revenue metrics

Kronos Bio, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$0K
8 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Kronos Bio, Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
KRON revenue by year · KRON revenue history · KRON annual revenue data

Compare revenue vs peers

Biotechnology

Compare KRON revenue against listed peers. Click any row to open that company's revenue tab.

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Kronos Bio, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Kronos Bio, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Kronos Bio, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

KRON revenue · 4 questions

KRON's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

KRON revenueKRON annual revenuewhat is KRON revenueKRON TTM revenue

Source: FMP · Kronos Bio, Inc. SEC filings · GAAP · Kronos Bio, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026